|
|
Diabetes News Archive
June 24, 2010, 17:04 GMT
BMS's Diabetes Drug Dapagliflozin Shows Promise - Lancet
June 24, 2010, 16:09 GMT
THURSDAY, June 24 (HealthDay News) -- Diabetes appears to double the risk of dying from a heart attack, stroke or other heart condition, a new study finds.
June 24, 2010, 16:05 GMT
Today's Lancet is a special issue on diabetes, published to coincide with the 70th Scientific Sessions meeting of the American Diabetes Association (ADA) in Orlando, Florida on June 2629. Four Articles add precision to cardiovascular risk in people with type 2 diabetes, or describe new strategies in pharmacological pathways, dosing, and delivery.
June 24, 2010, 13:03 GMT
THURSDAY, June 24 (HealthDay News) -- People with diabetes who are hospitalized for sudden worsening of symptoms of the common lung disease known as chronic obstructive pulmonary disease (COPD) have longer hospital stays and are more likely to die than COPD patients without diabetes, a new study has found.
June 24, 2010, 08:16 GMT
The American Diabetes Association, the nation's leading voluntary health organization in the fight to stop diabetes, announced today that several leading researchers, clinicians, volunteers and educators in the diabetes field will be presented with national achievement awards this week. The following leaders will receive the achievement awards at the Association's National Board Meeting ...
June 24, 2010, 05:52 GMT
This market research report analyzes the diabetes care devices market in Brazil, Russia, India, and China (BRIC) over the period 2009-2014. The report categorizes the overall market for diabetes care devices into the submarkets for insulin pumps, self-monitoring blood glucose systems, and continuous glucose monitoring systems.
June 24, 2010, 05:00 GMT
Cellonis, a Beijing and HK-based biotech company, with its new personalized diabetes treatment concept has demonstrated an amazing improvement in their treated patients' conditions.
2010 - 2014 - June 24, 2010, 03:23 GMT
ReportsandReports announces it will carry the Diabetes Care Devices Market in Brazil, Russia, India, and China Market Research Report in its store.
June 24, 2010, 00:17 GMT
The CHER Diabetes Education Center has moved to the Riverpoint One Building, 501 N. Riverpoint Blvd., Suite 245. The center has been serving the Spokane area for 22 years, providing classes and one-on-one consultations in diabetes education for Type 1 diabetes, Type 2 diabetes, pre-diabetes and gestational diabetes. For more information about the center and its resources, call (509) 232-8145 or ...
|
|